Gene · 6392
Papers2,836
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 2,836
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RNAseq reveals extensive metabolic disruptions in the sensitive SF-295 cell line treated with schweinfurthins. | Sci Rep | 2022 | 35013404 | PubTator, text mining | PubMed |
| Loss of SDHB Induces a Metabolic Switch in the hPheo1 Cell Line toward Enhanced OXPHOS. | Int J Mol Sci | 2022 | 35008989 | PubTator, text mining | PubMed |
| COL17A1 germline variant p.Ser1029Ala and mucosal malignant melanoma: An autopsy study. | Mol Clin Oncol | 2022 | 34987801 | PubTator, text mining | PubMed |
Quantification of succinic acid levels, linked to succinate dehydrogenase (SDH) dysfunctions, by an automated and fully validated liquid chromatography tandem mass spectrometry method suitable for multi-matrix applications. | J Chromatogr B Analyt Technol Biomed Life Sci | 2022 | 34974318 | PubTator, text mining | PubMed |
| Dichotomous Responses to Chronic Fetal Hypoxia Lead to a Predetermined Aging Phenotype. | Mol Cell Proteomics | 2022 | 34958949 | PubTator, text mining | PubMed |
| Dutch founder SDHB exon 3 deletion in patients with pheochromocytoma-paraganglioma in South Africa. | Endocr Connect | 2022 | 34939938 | PubTator, text mining | PubMed |
| Management of SHDB positive patient with metastatic bilateral giant retroperitoneal paragangliomas. | Urol Case Rep | 2022 | 34926161 | PubTator, text mining | PubMed |
| RNA Sequencing for Elucidating an Intronic Variant of Uncertain Significance (SDHD c.314+3A>T) in Splicing Site Consensus Sequences. | Ann Lab Med | 2022 | 34907111 | PubTator, text mining | PubMed |
| Quantifying evidence toward pathogenicity for rare phenotypes: The case of succinate dehydrogenase genes, SDHB and SDHD. | Genet Med | 2022 | 34906457 | PubTator, text mining | PubMed |
| Corrigendum to: Personalized Management of Pheochromocytoma and Paraganglioma. | Endocr Rev | 2022 | 34904662 | PubTator, text mining | PubMed |
| Investigating the role of somatic sequencing platforms for phaeochromocytoma and paraganglioma in a large UK cohort. | Clin Endocrinol (Oxf) | 2022 | 34870338 | PubTator, text mining | PubMed |
| Efficacy and safety of 225Ac-DOTATATE targeted alpha therapy in metastatic paragangliomas: a pilot study. | Eur J Nucl Med Mol Imaging | 2022 | 34837103 | PubTator, text mining | PubMed |
| MicroRNA-101-3p Modulates Mitochondrial Metabolism via the Regulation of Complex II Assembly. | J Mol Biol | 2022 | 34808225 | PubTator, text mining | PubMed |
| Genetic spectrum in a Canadian cohort of apparently sporadic pheochromocytomas and paragangliomas: New data on multigene panel retesting over time. | Clin Endocrinol (Oxf) | 2022 | 34750850 | PubTator, text mining | PubMed |
| Succinate dehydrogenase deficient renal cell carcinoma: A case report. | Urol Case Rep | 2022 | 34712582 | PubTator, text mining | PubMed |
| Taming the Wild-Type Gastrointestinal Stromal Tumor: Improved Tissue Culture. | Clin Cancer Res | 2022 | 34711630 | PubTator, text mining | PubMed |
| Lessons learned from unsolicited findings in clinical exome sequencing of 16,482 individuals. | Eur J Hum Genet | 2022 | 34697415 | PubTator, text mining | PubMed |
| SBSA: an online service for somatic binding sequence annotation. | Nucleic Acids Res | 2022 | 34606615 | PubTator, text mining | PubMed |
| A 15-year pheochromocytoma and paraganglioma experience in a single centre: a Singapore perspective. | Singapore Med J | 2022 | 34602493 | PubTator, text mining | PubMed |
| Breast Radiation Therapy-Related Treatment Outcomes in Patients With or Without Germline Mutations on Multigene Panel Testing. | Int J Radiat Oncol Biol Phys | 2022 | 34582940 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6392/papers?page=34